| Nano strategies for berberine delivery, a natural alkaloid of Berberis E Mirhadi, M Rezaee, B Malaekeh-Nikouei Biomedicine & Pharmacotherapy 104, 465-473, 2018 | 199 | 2018 |
| The role of nanotechnology in combating biofilm-based antibiotic resistance B Malaekeh-Nikouei, BSF Bazzaz, E Mirhadi, AS Tajani, B Khameneh Journal of Drug Delivery Science and Technology 60, 101880, 2020 | 103 | 2020 |
| Redox-sensitive nanoscale drug delivery systems for cancer treatment E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ... International journal of pharmaceutics 589, 119882, 2020 | 96 | 2020 |
| Resveratrol: Mechanistic and therapeutic perspectives in pulmonary arterial hypertension E Mirhadi, BD Roufogalis, M Banach, M Barati, A Sahebkar Pharmacological research 163, 105287, 2021 | 71 | 2021 |
| An updated review on therapeutic effects of nanoparticle-based formulations of saffron components (safranal, crocin, and crocetin) E Mirhadi, H Nassirli, B Malaekeh-Nikouei Journal of Pharmaceutical Investigation 50 (1), 47-58, 2020 | 59 | 2020 |
| Perlite-SO3H nanoparticles as an efficient and reusable catalyst for one-pot three-component synthesis of 1, 2-dihydro-1-aryl-naphtho [1, 2-e][1, 3] oxazine-3-one derivatives … A Ramazani, M Rouhani, E Mirhadi, M Sheikhi, K Ślepokura, T Lis Nanochemistry Research 1 (1), 87-107, 2016 | 45 | 2016 |
| Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting MF Maleki, A Jafari, E Mirhadi, A Askarizadeh, B Golichenari, ... International journal of pharmaceutics 572, 118716, 2019 | 37 | 2019 |
| Redox-sensitive doxorubicin liposome: A formulation approach for targeted tumor therapy E Mirhadi, M Mashreghi, A Askarizadeh, A Mehrabian, SH Alavizadeh, ... Scientific reports 12 (1), 11310, 2022 | 31 | 2022 |
| Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy A Askarizadeh, M Mashreghi, E Mirhadi, F Mirzavi, VH Shargh, A Badiee, ... Cancer nanotechnology 14 (1), 18, 2023 | 22 | 2023 |
| The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity S Dadpour, A Mehrabian, M Arabsalmani, E Mirhadi, A Askarizadeh, ... IET nanobiotechnology 16 (7-8), 259-272, 2022 | 21 | 2022 |
| Perlite-SO E Mirhadi, A Ramazani, M Rouhani, SW Joo chemija 24 (4), 320-324, 2013 | 15 | 2013 |
| Amino acid coordination complex mediates cisplatin entrapment within PEGylated liposome: An implication in colorectal cancer therapy E Mirhadi, F Gheybi, N Mahmoudi, M Hemmati, F Soleymanian, ... International Journal of Pharmaceutics 623, 121946, 2022 | 11 | 2022 |
| Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension E Mirhadi, P Kesharwani, TP Johnston, A Sahebkar Drug Discovery Today 28 (6), 103599, 2023 | 10 | 2023 |
| Reactive oxygen species-responsive drug delivery systems: a new approach in nanomedicine E Mirhadi, M Majeed, P Kesharwani, A Sahebkar Current Medicinal Chemistry 29 (25), 4320-4323, 2022 | 9 | 2022 |
| The impact of phospholipids with high transition temperature to enhance redox-sensitive liposomal doxorubicin efficacy in colon carcinoma model E Mirhadi, A Askarizadeh, L Farhoudi, M Mashreghi, S Behboodifar, ... Chemistry and Physics of Lipids 261, 105396, 2024 | 5 | 2024 |
| Biomedicine & Pharmacotherapy E Mirhadi, M Rezaee, B Malaekeh-Nikouei Nano strategies for berberine delivery, a natural alkaloid of Berberis 104 …, 2018 | 5 | 2018 |
| Liposomal delivery of organoselenium-cisplatin complex as a novel therapeutic approach for colon cancer therapy S Khabbazian, E Mirhadi, F Gheybi, A Askarizadeh, MR Jaafari, ... Colloids and Surfaces B: Biointerfaces 242, 114085, 2024 | 4 | 2024 |
| Effect of bariatric surgery on serum amyloid a protein: a systematic review and meta-analysis T Jamialahamdi, E Mirhadi, SL Atkin, CW le Roux, M Kroh, W Almahmeed, ... Obesity Surgery 33 (11), 3602-3610, 2023 | 3 | 2023 |
| Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer A Askarizadeh, M Mashreghi, E Mirhadi, A Mehrabian, V Heravi Shargh, ... Journal of Liposome Research 34 (2), 221-238, 2024 | 2 | 2024 |
| Curcumin: historical background, introduction, structure, and physicochemical attributes E Mirhadi, A Tasbandi, P Kesharwani, A Sahebkar Curcumin-Based Nanomedicines as Cancer Therapeutics, 3-22, 2024 | 2 | 2024 |
Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical Nanotechnologymums.ac.ir의 이메일 확인됨